On 5/11/2017, Shares of AmpliPhi Biosciences Corporation (PNK:APHB) closed at $1.11 in last trading day. After noting the initial trading entry at $1.13, it reached to a day’s high of $1.30 and moved to a day’s low of $1.09. The recent daily volume was 2.66 million as contrast to it’s an average volume of 563.41 thousand.
The last close of the AmpliPhi Biosciences Corporation stock reflects that it traded up +32.10% from its 50-day moving average of $0.84. The stock traded above +68.33% to its 200-day MA of $0.66. Furthermore, it moved lower -97.02% from its 52-week high of $37.23 and +1.83% up from $1.09, which is 52-week low of the stock.
AmpliPhi Biosciences Corporation’s (APHB) moved with shift of -61.72% in the past week. Over the last three months, the shares of the company have changed 113.46% and performed 11.00% over the last six months. The stock currently has Monthly Volatility of 24.04% and Weekly Volatility of 10.82%.
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) finalized the last transaction at value of $3.97, with a daily change of +22.15% or +0.72 points. The company maintained volume of 972.03 thousand shares. In past trading day, the stock hit the maximum price of $4.08 and touched to minimum value of $3.20. It has a market cap of $ 100.93M.
As of last trade close, the stock is trading downside -2.65% from its one year high of $4.08 and moved +2953.85% upward from $0.13, which is one year low of the stock.
The stock traded above +378.81% from its 50-day moving average of $0.83. Furthermore, the stock moved up +993.03% to its 200-day MA of $ 0.36.
During the last month, Rexahn Pharmaceuticals, Inc.’s (RNN) has changed 542.39% and performed 2459.64% over the last 6 months. The mean rating score for this stock is at 1.70. This rating scale contains from 1 to 5 with 5 representing a Strong Sell, 1 signifying a Strong Buy and 3 demonstrating a Hold. The Volatility was noted at 12.19% in recent month and observed Weekly Volatility of 15.23%.